within Pharmacolibrary.Drugs.R_RespiratorySystem.R03B_OtherDrugsForObstructiveAirwayDiseasesInhalants.R03BA05_Fluticasone;

model Fluticasone
  extends Pharmacolibrary.Drugs.ATC.R.R03BA05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R03BA05</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Fluticasone is a synthetic corticosteroid used as an anti-inflammatory and immunosuppressive agent, primarily for the management of asthma and allergic rhinitis. Administered via inhalation, it reduces airway inflammation. Widely approved and in clinical use globally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after inhaled administration.</p><h4>References</h4><ol><li><p>Gillespie, M, et al., &amp; Steinfeld, J (2015). Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus Diskus and metered-dose inhalers. <i>Allergy and asthma proceedings</i> None None–None. DOI:<a href=\"https://doi.org/10.2500/.aap.2015.36.3889\">10.2500/.aap.2015.36.3889</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26219638/\">https://pubmed.ncbi.nlm.nih.gov/26219638</a></p></li><li><p>Gillespie, M, et al., &amp; Steinfeld, J (2015). Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler. <i>Allergy and asthma proceedings</i> 36(5) 365–371. DOI:<a href=\"https://doi.org/10.2500/aap.2015.36.3889\">10.2500/aap.2015.36.3889</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26314817/\">https://pubmed.ncbi.nlm.nih.gov/26314817</a></p></li><li><p>Anwar, MM, et al., &amp; Zaghary, WA (2015). Salmeterol Xinafoate. <i>Profiles of drug substances, excipients, and related methodology</i> 40 321–369. DOI:<a href=\"https://doi.org/10.1016/bs.podrm.2015.02.002\">10.1016/bs.podrm.2015.02.002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26051688/\">https://pubmed.ncbi.nlm.nih.gov/26051688</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Fluticasone;
